A mobile health intervention in caregivers of patients undergoing hematopoietic cell transplantation: a randomized controlled trial to examine health-related quality of life

Abstract Background Caregivers are essential in supporting cancer patients, especially those undergoing hematopoietic cell transplantation (HCT). While traditional interventions have been beneficial for improving health-related quality of life (HRQOL), they typically require significant time and sta...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiao Cao, Michelle Rozwadowski, Thomas M. Braun, Noelle E. Carlozzi, Afton L. Hassett, Amanda K. Johnson, Evan Shereck, David A. Hanauer, Sung Won Choi
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Digital Health
Subjects:
Online Access:https://doi.org/10.1186/s44247-025-00165-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849332224703332352
author Xiao Cao
Michelle Rozwadowski
Thomas M. Braun
Noelle E. Carlozzi
Afton L. Hassett
Amanda K. Johnson
Evan Shereck
David A. Hanauer
Sung Won Choi
author_facet Xiao Cao
Michelle Rozwadowski
Thomas M. Braun
Noelle E. Carlozzi
Afton L. Hassett
Amanda K. Johnson
Evan Shereck
David A. Hanauer
Sung Won Choi
author_sort Xiao Cao
collection DOAJ
description Abstract Background Caregivers are essential in supporting cancer patients, especially those undergoing hematopoietic cell transplantation (HCT). While traditional interventions have been beneficial for improving health-related quality of life (HRQOL), they typically require significant time and staff resources. To address this, we developed the Roadmap mHealth app, which incorporates resilience-building features based on positive psychology. The app integrates Fitbit® devices to monitor and visualize steps, sleep, and self-reported mood in the Roadmap app. A two-arm randomized controlled trial (RCT) was conducted to evaluate the impact of Roadmap’s positive activities on caregiver HRQOL, measured by PROMIS® Global Health (physical and mental components), at day-120 post-transplant compared to assessment-only controls. Results From September 08, 2020 to July 31, 2023, 168 dyads enrolled in the Roadmap study (82 intervention, 87 control). At day-120 post-HCT, there were no significant differences in PROMIS® Global Mental Health (48.18 vs. 48.16) or Global Physical Health (50.19 vs. 49.52) T-scores between the intervention and control arms. However, among caregivers who used positive activities and chat forum features in the intervention arm, daily mood significantly improved over time (β = 0.0082, P < 0.001, 95% CI = [0.0060, 0.0010]). Improved daily mood scores were positively associated with better PROMIS® Global Mental Health at days 30 and 120 post-HCT (β = 0.6076, P = 0.03, 95% CI = [0.0494, 1.166]). The Fitbit® device and Roadmap app also received net favorable ratings in feasibility and acceptability, indicating that they were generally easy-to-understand, set up, and use, and superior Mobile App Rating Scale (MARS) scores compared to published mental health apps, with no significant differences between study arms. Compliance with the intervention or control app declined over time. Conclusions While the primary outcome, PROMIS® Global Health, did not differ between arms, caregivers who engaged in positive activities and chat forum through the app experienced a significant improvement in mood compared to those who did not. Additionally, caregivers reported the study as feasible and acceptable over the 120-day study period. Future directions for the Roadmap app are discussed based on these findings. Trial registration ClinicalTrials.gov: NCT04094844, Registered 09–16-2019.
format Article
id doaj-art-9aa3cb6f0bb2490d8f765eacf0eafd2a
institution Kabale University
issn 2731-684X
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series BMC Digital Health
spelling doaj-art-9aa3cb6f0bb2490d8f765eacf0eafd2a2025-08-20T03:46:16ZengBMCBMC Digital Health2731-684X2025-07-013111510.1186/s44247-025-00165-5A mobile health intervention in caregivers of patients undergoing hematopoietic cell transplantation: a randomized controlled trial to examine health-related quality of lifeXiao Cao0Michelle Rozwadowski1Thomas M. Braun2Noelle E. Carlozzi3Afton L. Hassett4Amanda K. Johnson5Evan Shereck6David A. Hanauer7Sung Won Choi8Department of Pediatrics, University of MichiganDepartment of Pediatrics, University of MichiganDepartment of Biostatistics, School of Public Health, University of MichiganDepartment of Physical Medicine and Rehabilitation, University of MichiganDepartment of Anesthesiology, University of MichiganDepartment of Pediatrics, University of UtahDepartment of Pediatrics, Oregon Health & Science UniversityDepartment of Learning Health Sciences, University of MichiganDepartment of Pediatrics, University of MichiganAbstract Background Caregivers are essential in supporting cancer patients, especially those undergoing hematopoietic cell transplantation (HCT). While traditional interventions have been beneficial for improving health-related quality of life (HRQOL), they typically require significant time and staff resources. To address this, we developed the Roadmap mHealth app, which incorporates resilience-building features based on positive psychology. The app integrates Fitbit® devices to monitor and visualize steps, sleep, and self-reported mood in the Roadmap app. A two-arm randomized controlled trial (RCT) was conducted to evaluate the impact of Roadmap’s positive activities on caregiver HRQOL, measured by PROMIS® Global Health (physical and mental components), at day-120 post-transplant compared to assessment-only controls. Results From September 08, 2020 to July 31, 2023, 168 dyads enrolled in the Roadmap study (82 intervention, 87 control). At day-120 post-HCT, there were no significant differences in PROMIS® Global Mental Health (48.18 vs. 48.16) or Global Physical Health (50.19 vs. 49.52) T-scores between the intervention and control arms. However, among caregivers who used positive activities and chat forum features in the intervention arm, daily mood significantly improved over time (β = 0.0082, P < 0.001, 95% CI = [0.0060, 0.0010]). Improved daily mood scores were positively associated with better PROMIS® Global Mental Health at days 30 and 120 post-HCT (β = 0.6076, P = 0.03, 95% CI = [0.0494, 1.166]). The Fitbit® device and Roadmap app also received net favorable ratings in feasibility and acceptability, indicating that they were generally easy-to-understand, set up, and use, and superior Mobile App Rating Scale (MARS) scores compared to published mental health apps, with no significant differences between study arms. Compliance with the intervention or control app declined over time. Conclusions While the primary outcome, PROMIS® Global Health, did not differ between arms, caregivers who engaged in positive activities and chat forum through the app experienced a significant improvement in mood compared to those who did not. Additionally, caregivers reported the study as feasible and acceptable over the 120-day study period. Future directions for the Roadmap app are discussed based on these findings. Trial registration ClinicalTrials.gov: NCT04094844, Registered 09–16-2019.https://doi.org/10.1186/s44247-025-00165-5Family caregiversHematopoietic cell transplantation (HCT)Health-related quality of life (HRQOL)Digital technologiesMobile health (mHealth)Positive psychology
spellingShingle Xiao Cao
Michelle Rozwadowski
Thomas M. Braun
Noelle E. Carlozzi
Afton L. Hassett
Amanda K. Johnson
Evan Shereck
David A. Hanauer
Sung Won Choi
A mobile health intervention in caregivers of patients undergoing hematopoietic cell transplantation: a randomized controlled trial to examine health-related quality of life
BMC Digital Health
Family caregivers
Hematopoietic cell transplantation (HCT)
Health-related quality of life (HRQOL)
Digital technologies
Mobile health (mHealth)
Positive psychology
title A mobile health intervention in caregivers of patients undergoing hematopoietic cell transplantation: a randomized controlled trial to examine health-related quality of life
title_full A mobile health intervention in caregivers of patients undergoing hematopoietic cell transplantation: a randomized controlled trial to examine health-related quality of life
title_fullStr A mobile health intervention in caregivers of patients undergoing hematopoietic cell transplantation: a randomized controlled trial to examine health-related quality of life
title_full_unstemmed A mobile health intervention in caregivers of patients undergoing hematopoietic cell transplantation: a randomized controlled trial to examine health-related quality of life
title_short A mobile health intervention in caregivers of patients undergoing hematopoietic cell transplantation: a randomized controlled trial to examine health-related quality of life
title_sort mobile health intervention in caregivers of patients undergoing hematopoietic cell transplantation a randomized controlled trial to examine health related quality of life
topic Family caregivers
Hematopoietic cell transplantation (HCT)
Health-related quality of life (HRQOL)
Digital technologies
Mobile health (mHealth)
Positive psychology
url https://doi.org/10.1186/s44247-025-00165-5
work_keys_str_mv AT xiaocao amobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT michellerozwadowski amobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT thomasmbraun amobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT noelleecarlozzi amobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT aftonlhassett amobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT amandakjohnson amobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT evanshereck amobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT davidahanauer amobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT sungwonchoi amobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT xiaocao mobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT michellerozwadowski mobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT thomasmbraun mobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT noelleecarlozzi mobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT aftonlhassett mobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT amandakjohnson mobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT evanshereck mobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT davidahanauer mobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife
AT sungwonchoi mobilehealthinterventionincaregiversofpatientsundergoinghematopoieticcelltransplantationarandomizedcontrolledtrialtoexaminehealthrelatedqualityoflife